Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)
NCT00298870
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
172
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Tuberculosis
Interventions
DRUG:
Isoniazid
DRUG:
isoniazed
Sponsor
Osaka University